www.advanzpharma.com
Open in
urlscan Pro
178.128.160.224
Public Scan
Submitted URL: https://abcur.co.uk/
Effective URL: https://www.advanzpharma.com/
Submission: On August 24 via api from US — Scanned from DE
Effective URL: https://www.advanzpharma.com/
Submission: On August 24 via api from US — Scanned from DE
Form analysis 8 forms found in the DOM
<form>
<fieldset>
<legend class="visuallyhidden">Consent Selection</legend>
<div id="CybotCookiebotDialogBodyFieldsetInnerContainer">
<div class="CybotCookiebotDialogBodyLevelButtonWrapper"><label class="CybotCookiebotDialogBodyLevelButtonLabel" for="CybotCookiebotDialogBodyLevelButtonNecessary"><strong class="CybotCookiebotDialogBodyLevelButtonDescription">Necessary
</strong></label>
<div class="CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogBodyLevelButtonSliderWrapperDisabled"><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonNecessary"
class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelButtonDisabled" disabled="disabled" checked="checked"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></div>
</div>
<div class="CybotCookiebotDialogBodyLevelButtonWrapper"><label class="CybotCookiebotDialogBodyLevelButtonLabel" for="CybotCookiebotDialogBodyLevelButtonPreferences"><strong class="CybotCookiebotDialogBodyLevelButtonDescription">Preferences
</strong></label>
<div class="CybotCookiebotDialogBodyLevelButtonSliderWrapper"><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonPreferences" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox"
data-target="CybotCookiebotDialogBodyLevelButtonPreferencesInline" checked="checked" tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></div>
</div>
<div class="CybotCookiebotDialogBodyLevelButtonWrapper"><label class="CybotCookiebotDialogBodyLevelButtonLabel" for="CybotCookiebotDialogBodyLevelButtonStatistics"><strong class="CybotCookiebotDialogBodyLevelButtonDescription">Statistics
</strong></label>
<div class="CybotCookiebotDialogBodyLevelButtonSliderWrapper"><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonStatistics" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox"
data-target="CybotCookiebotDialogBodyLevelButtonStatisticsInline" checked="checked" tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></div>
</div>
<div class="CybotCookiebotDialogBodyLevelButtonWrapper"><label class="CybotCookiebotDialogBodyLevelButtonLabel" for="CybotCookiebotDialogBodyLevelButtonMarketing"><strong class="CybotCookiebotDialogBodyLevelButtonDescription">Marketing
</strong></label>
<div class="CybotCookiebotDialogBodyLevelButtonSliderWrapper"><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonMarketing" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox"
data-target="CybotCookiebotDialogBodyLevelButtonMarketingInline" checked="checked" tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></div>
</div>
</div>
</fieldset>
</form><form><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonNecessaryInline" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelButtonDisabled" disabled="disabled" checked="checked"> <span
class="CybotCookiebotDialogBodyLevelButtonSlider"></span></form><form><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonPreferencesInline" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox" data-target="CybotCookiebotDialogBodyLevelButtonPreferences"
checked="checked" tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></form><form><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonStatisticsInline" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox" data-target="CybotCookiebotDialogBodyLevelButtonStatistics"
checked="checked" tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></form><form><input type="checkbox" id="CybotCookiebotDialogBodyLevelButtonMarketingInline" class="CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox" data-target="CybotCookiebotDialogBodyLevelButtonMarketing" checked="checked"
tabindex="0"> <span class="CybotCookiebotDialogBodyLevelButtonSlider"></span></form><form class="CybotCookiebotDialogBodyLevelButtonSliderWrapper"><input type="checkbox" id="CybotCookiebotDialogBodyContentCheckboxPersonalInformation" class="CybotCookiebotDialogBodyLevelButton"> <span
class="CybotCookiebotDialogBodyLevelButtonSlider"></span></form>GET https://www.advanzpharma.com/search/results
<form method="get" action="https://www.advanzpharma.com/search/results">
<input type="hidden" name="CRAFT_CSRF_TOKEN" value="9P87wOjjY4f4hajW8WUnrBDlI8XWJ1a0ffF3nJ9tKjUvO-6of3hvQIOzQfSx1Q7Gk8LgvKBWTuZb3GCspWhm_CrANt_zXhtjQFmWwDsbNjU=">
<input type="search" name="q" placeholder="Search">
</form>Name: mc-embedded-subscribe-form — POST https://advanzpharma.us2.list-manage.com/subscribe/post?u=3e5003d3bacd2f43ff254b298&id=00c98dc602&v_id=4454&f_id=00dd5fe0f0
<form action="https://advanzpharma.us2.list-manage.com/subscribe/post?u=3e5003d3bacd2f43ff254b298&id=00c98dc602&v_id=4454&f_id=00dd5fe0f0" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate"
target="_self" novalidate="">
<div id="mc_embed_signup_scroll">
<div class="form-row">
<div class="form-group">
<div class="mc-field-group">
<label for="mce-FNAME" class="u--sr-only">Name</label><input type="text" name="FNAME" class="required text" id="mce-FNAME" required="" value="" placeholder="Name">
</div>
</div>
</div>
<div class="form-row">
<div class="form-group">
<div class="mc-field-group">
<label for="mce-EMAIL" class="u--sr-only">Email</label><input type="email" name="EMAIL" class="required email" id="mce-EMAIL" required="" value="" placeholder="Email">
</div>
</div>
</div>
<div id="mergeRow-gdpr" class="mergeRow gdpr-mergeRow content__gdprBlock mc-field-group">
<div class="content__gdpr">
<label class="u--sr-only">Marketing Permissions</label>
<p>Please select all the ways you would like to hear from ADVANZ PHARMA:</p>
<div class="form-row">
<fieldset class="mc_fieldset gdprRequired mc-field-group" name="interestgroup_field">
<div class="wf-checkbox">
<input type="checkbox" id="gdpr25834" name="gdpr[25834]" class="gdpr" value="Y">
<label class="checkbox subfield" for="gdpr25834">
<span>Email</span>
</label>
</div>
</fieldset>
</div>
<p class="font-size-tiny">You can unsubscribe at any time by clicking the link in the footer of our emails.</p>
</div>
<div class="content__gdprLegal font-size-tiny">
<p class="font-size-tiny">We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. <a href="https://mailchimp.com/legal/terms">
<u>Learn more</u>
</a> about Mailchimp's privacy practices.</p>
</div>
</div>
<div id="mce-responses" class="clear foot">
<div class="response" id="mce-error-response" style="display: none;"></div>
<div class="response" id="mce-success-response" style="display: none;"></div>
</div>
<div style="position: absolute; left: -5000px;" aria-hidden="true"> /* real people should not fill this in and expect good things - do not remove this or risk form bot signups */ <input type="text" name="b_3e5003d3bacd2f43ff254b298_00c98dc602"
tabindex="-1" value="">
</div>
<div class="optionalParent">
<div class="clear foot">
<input type="submit" name="subscribe" id="mc-embedded-subscribe" class="button" value="Subscribe">
</div>
</div>
</div>
</form>Text Content
Powered by Cookiebot
* Consent
* Details
* [#IABV2SETTINGS#]
* About
THIS WEBSITE USES COOKIES
We use cookies to personalise content and ads, to provide social media features
and to analyse our traffic. We also share information about your use of our site
with our social media, advertising and analytics partners who may combine it
with other information that you’ve provided to them or that they’ve collected
from your use of their services.
Consent Selection
Necessary
Preferences
Statistics
Marketing
Show details
* Necessary 11
Necessary cookies help make a website usable by enabling basic functions like
page navigation and access to secure areas of the website. The website cannot
function properly without these cookies.
* Cision
1
Learn more about this provider
cUsed in order to detect spam and improve the website's security.
Expiry: 6 monthsType: HTTP Cookie
* Cookiebot
2
Learn more about this provider
1.gifUsed to count the number of sessions to the website, necessary for
optimizing CMP product delivery.
Expiry: SessionType: Pixel Tracker
CookieConsentStores the user's cookie consent state for the current domain
Expiry: 1 yearType: HTTP Cookie
* drivetheweb.com
mediaroom.com
newswire.ca
4
__cf_bm [x4]This cookie is used to distinguish between humans and bots.
This is beneficial for the website, in order to make valid reports on the
use of their website.
Expiry: 1 dayType: HTTP Cookie
* mediaroom.com
2
__cfruidThis cookie is a part of the services provided by Cloudflare -
Including load-balancing, deliverance of website content and serving DNS
connection for website operators.
Expiry: SessionType: HTTP Cookie
cf_clearanceThis cookie is used to distinguish between humans and bots.
Expiry: 1 yearType: HTTP Cookie
* www.advanzpharma.com
2
CRAFT_CSRF_TOKENEnsures visitor browsing-security by preventing cross-site
request forgery. This cookie is essential for the security of the website
and visitor.
Expiry: SessionType: HTTP Cookie
CraftSessionIdSets a unique ID for the session. This allows the website to
obtain data on visitor behaviour for statistical purposes.
Expiry: SessionType: HTTP Cookie
* Preferences 0
Preference cookies enable a website to remember information that changes the
way the website behaves or looks, like your preferred language or the region
that you are in.
We do not use cookies of this type.
* Statistics 6
Statistic cookies help website owners to understand how visitors interact
with websites by collecting and reporting information anonymously.
* Google
1
Learn more about this provider
Some of the data collected by this provider is for the purposes of
personalization and measuring advertising effectiveness.
_dc_gtm_UA-#Used by Google Tag Manager to control the loading of a Google
Analytics script tag.
Expiry: 1 dayType: HTTP Cookie
* Microsoft
2
Learn more about this provider
c.gifCollects data on the user’s navigation and behavior on the website.
This is used to compile statistical reports and heatmaps for the website
owner.
Expiry: SessionType: Pixel Tracker
CLIDPending
Expiry: 1 yearType: HTTP Cookie
* stats.drivetheweb.com
3
_pk_id#Collects statistics on the user's visits to the website, such as
the number of visits, average time spent on the website and what pages
have been read.
Expiry: 1 yearType: HTTP Cookie
_pk_ref#Used by Piwik Analytics Platform to identify the referring website
from which the visitor has come.
Expiry: 6 monthsType: HTTP Cookie
_pk_ses#Used by Piwik Analytics Platform to track page requests from the
visitor during the session.
Expiry: 1 dayType: HTTP Cookie
* Marketing 13
Marketing cookies are used to track visitors across websites. The intention
is to display ads that are relevant and engaging for the individual user and
thereby more valuable for publishers and third party advertisers.
* Google
4
Learn more about this provider
Some of the data collected by this provider is for the purposes of
personalization and measuring advertising effectiveness.
_gaUsed to send data to Google Analytics about the visitor's device and
behavior. Tracks the visitor across devices and marketing channels.
Expiry: 2 yearsType: HTTP Cookie
_ga_#Used to send data to Google Analytics about the visitor's device and
behavior. Tracks the visitor across devices and marketing channels.
Expiry: 2 yearsType: HTTP Cookie
_gidUsed to send data to Google Analytics about the visitor's device and
behavior. Tracks the visitor across devices and marketing channels.
Expiry: 1 dayType: HTTP Cookie
collectUsed to send data to Google Analytics about the visitor's device
and behavior. Tracks the visitor across devices and marketing channels.
Expiry: SessionType: Pixel Tracker
* MediMath
1
Learn more about this provider
uuidCollects data on the user's visits to the website, such as what pages
have been loaded. The registered data is used for targeted ads.
Expiry: 1 yearType: HTTP Cookie
* Microsoft
7
Learn more about this provider
MR [x2]Pending
Expiry: 7 daysType: HTTP Cookie
MUID [x2]Pending
Expiry: 1 yearType: HTTP Cookie
SRM_BPending
Expiry: 1 yearType: HTTP Cookie
ANONCHKPending
Expiry: 1 dayType: HTTP Cookie
SMPending
Expiry: SessionType: HTTP Cookie
* advanzpharma.mediaroom.com
1
piwik.phpSets a unique ID for the visitor, that allows third party
advertisers to target the visitor with relevant advertisement. This
pairing service is provided by third party advertisement hubs, which
facilitates real-time bidding for advertisers.
Expiry: SessionType: Pixel Tracker
* Unclassified 1
Unclassified cookies are cookies that we are in the process of classifying,
together with the providers of individual cookies.
* Cision
1
Learn more about this provider
c/img/1x1.gifPending
Expiry: SessionType: Pixel Tracker
Cross-domain consent[#BULK_CONSENT_DOMAINS_COUNT#] [#BULK_CONSENT_TITLE#]
List of domains your consent applies to: [#BULK_CONSENT_DOMAINS#]
Cookie declaration last updated on 01.08.24 by Cookiebot
[#IABV2_TITLE#]
[#IABV2_BODY_INTRO#]
[#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#]
[#IABV2_BODY_PREFERENCE_INTRO#]
[#IABV2_LABEL_PURPOSES#]
[#IABV2_BODY_PURPOSES_INTRO#]
[#IABV2_BODY_PURPOSES#]
[#IABV2_LABEL_FEATURES#]
[#IABV2_BODY_FEATURES_INTRO#]
[#IABV2_BODY_FEATURES#]
[#IABV2_LABEL_PARTNERS#]
[#IABV2_BODY_PARTNERS_INTRO#]
[#IABV2_BODY_PARTNERS#]
Cookies are small text files that can be used by websites to make a user's
experience more efficient.
The law states that we can store cookies on your device if they are strictly
necessary for the operation of this site. For all other types of cookies we need
your permission.
This site uses different types of cookies. Some cookies are placed by third
party services that appear on our pages.
You can at any time change or withdraw your consent from the Cookie Declaration
on our website.
Learn more about who we are, how you can contact us and how we process personal
data in our Privacy Policy.
Please state your consent ID and date when you contact us regarding your
consent.
Do not sell or share my personal information
Deny Allow selection Customize
Allow all
Powered by Cookiebot by Usercentrics
* About
* News
* Partner of Choice
* Investors
* Careers
* Contact
Website Video
PARTNER OF CHOICE IN SPECIALTY, HOSPITAL, AND RARE DISEASE MEDICINES
Learn More
ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve
patients’ lives by providing the specialty, hospital, and rare disease medicines
they depend on.
Our ambition is to be a partner of choice for the commercialisation of
specialty, hospital, and rare disease medicines in Europe, Canada, and
Australia. In line with our ambition, we are partnering with innovative
biopharma and pharmaceutical development companies to bring medicines to
patients.
Headquartered in London, UK, we have commercial sales in more than 90 countries
globally and have a direct commercial presence in more than 20 countries,
including key countries in Europe, the US, Canada, and Australia.
Our Centre of Excellence in Mumbai, India, as well as an established global
distribution and commercialisation partner network complement our global
operations.
ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines,
specialty generics & biosimilars, and originator brands. Our products and
pipeline cover a broad range of therapeutic areas, including hepatology,
gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more
broadly, rare diseases.
We can only achieve our ambition with the passion of our dedicated and highly
qualified people, acting in line with our company values of entrepreneurship,
speed, and integrity.
×
YOU ARE LEAVING THE ADVANZ PHARMA SITE
If you agree, then please click "YES" to proceed. If you do not wish to be
linked to this website, please click "NO" to dismiss this message.
YES NO
LATEST NEWS —
Previous
PRESS RELEASES — 18 JUN 2024
ALVOTECH AND ADVANZ PHARMA SIGN COMMERCIALIZATION AGREEMENT FOR PROPOSED
BIOSIMILAR TO EYLEA® LD/HD IN EUROPE
Learn more
PRESS RELEASES — 27 MAR 2024
ADVANZ PHARMA AND ALLECRA THERAPEUTICS ANNOUNCE APPROVAL IN THE EUROPEAN UNION
FOR THE NEW ANTIBIOTIC COMBINATION EXBLIFEP® (CEFEPIME/ENMETAZOBACTAM) FOR THE
TREATMENT OF SEVERE INFECTIONS
Learn more
PRESS RELEASES — 26 JAN 2024
ADVANZ PHARMA RECEIVES POSITIVE CHMP OPINION FOR EXBLIFEP®
(CEFEPIME/ENMETAZOBACTAM)
Learn more
PRESS RELEASES — 07 NOV 2023
ADVANZ PHARMA ACQUIRES GLOBAL RIGHTS TO ANDROCUR® FROM BAYER
Learn more
PRESS RELEASES — 15 AUG 2024
EUROPEAN MEDICINES AGENCY CONFIRMS ACCEPTANCE OF MARKETING APPLICATION FOR
AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)
Learn more
PRESS RELEASES — 01 JUL 2024
ADVANZ PHARMA RESPONSE TO CHMP RECOMMENDATION PERTAINING TO EU CONDITIONAL
MARKETING AUTHORIZATION FOR OCALIVA® IN RARE DISEASE PRIMARY BILIARY CHOLANGITIS
Learn more
PRESS RELEASES — 18 JUN 2024
ALVOTECH AND ADVANZ PHARMA SIGN COMMERCIALIZATION AGREEMENT FOR PROPOSED
BIOSIMILAR TO EYLEA® LD/HD IN EUROPE
Learn more
PRESS RELEASES — 27 MAR 2024
ADVANZ PHARMA AND ALLECRA THERAPEUTICS ANNOUNCE APPROVAL IN THE EUROPEAN UNION
FOR THE NEW ANTIBIOTIC COMBINATION EXBLIFEP® (CEFEPIME/ENMETAZOBACTAM) FOR THE
TREATMENT OF SEVERE INFECTIONS
Learn more
PRESS RELEASES — 26 JAN 2024
ADVANZ PHARMA RECEIVES POSITIVE CHMP OPINION FOR EXBLIFEP®
(CEFEPIME/ENMETAZOBACTAM)
Learn more
PRESS RELEASES — 07 NOV 2023
ADVANZ PHARMA ACQUIRES GLOBAL RIGHTS TO ANDROCUR® FROM BAYER
Learn more
PRESS RELEASES — 15 AUG 2024
EUROPEAN MEDICINES AGENCY CONFIRMS ACCEPTANCE OF MARKETING APPLICATION FOR
AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)
Learn more
PRESS RELEASES — 01 JUL 2024
ADVANZ PHARMA RESPONSE TO CHMP RECOMMENDATION PERTAINING TO EU CONDITIONAL
MARKETING AUTHORIZATION FOR OCALIVA® IN RARE DISEASE PRIMARY BILIARY CHOLANGITIS
Learn more
PRESS RELEASES — 18 JUN 2024
ALVOTECH AND ADVANZ PHARMA SIGN COMMERCIALIZATION AGREEMENT FOR PROPOSED
BIOSIMILAR TO EYLEA® LD/HD IN EUROPE
Learn more
PRESS RELEASES — 27 MAR 2024
ADVANZ PHARMA AND ALLECRA THERAPEUTICS ANNOUNCE APPROVAL IN THE EUROPEAN UNION
FOR THE NEW ANTIBIOTIC COMBINATION EXBLIFEP® (CEFEPIME/ENMETAZOBACTAM) FOR THE
TREATMENT OF SEVERE INFECTIONS
Learn more
PRESS RELEASES — 26 JAN 2024
ADVANZ PHARMA RECEIVES POSITIVE CHMP OPINION FOR EXBLIFEP®
(CEFEPIME/ENMETAZOBACTAM)
Learn more
PRESS RELEASES — 07 NOV 2023
ADVANZ PHARMA ACQUIRES GLOBAL RIGHTS TO ANDROCUR® FROM BAYER
Learn more
Next
OUR PORTFOLIO —
ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines,
specialty generics & biosimilars, and originator brands
Our products cover a broad range of therapeutic areas, including hepatology,
gastroenterology, anti-infectives, critical care, endocrinology, oncology, CNS,
and, more broadly, rare diseases.
CAREERS & CULTURE —
The success of any company is driven by its people, and we are no different. We
aim to be the best team in the industry by embracing challenges and change. We
live our company values Entrepreneurship, Speed, and Integrity.
OUR PARTNERSHIPS —
Partnerships are a fundamental part of our business.. We work with >300 partners
in production, development, portfolio licensing, and commercialization. We
cooperate very closely with them and invest significantly to help broaden
patient access and to improve health outcomes.
CONTACT US —
Corporate Headquarters
Direct: +44 (0) 208 588 9100
Compliance Hotline:
+1 855 562 5982
www.advanzpharma.ethicspoint.com
SUBSCRIBE FOR THE LATEST PRESS RELEASES DELIVERED TO YOUR INBOX
Name
Email
Marketing Permissions
Please select all the ways you would like to hear from ADVANZ PHARMA:
Email
You can unsubscribe at any time by clicking the link in the footer of our
emails.
We use Mailchimp as our marketing platform. By clicking below to subscribe, you
acknowledge that your information will be transferred to Mailchimp for
processing. Learn more about Mailchimp's privacy practices.
/* real people should not fill this in and expect good things - do not remove
this or risk form bot signups */
×
YOU ARE LEAVING THE ADVANZ PHARMA SITE
If you agree, then please click "YES" to proceed. If you do not wish to be
linked to this website, please click "NO" to dismiss this message.
YES NO
* About
* News
* Partner of Choice
* Careers
* Contact
* Ethics & Transparency
* Modern Slavery Statement
* Product Risk Materials
* ADVANZ FOR LIFE
* Terms & Conditions
* Privacy Policy
* Recruitment Scams
* Follow us on LinkedIn
Copyright 2024 ADVANZ PHARMA®. All Rights Reserved
×
FORMAL SALE PROCESS
INFORMATION REGARDING FORMAL SALE PROCESS
ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN
CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS
(INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY
OBTAIN ACCESS TO THE INFORMATION IN THIS AREA OF THE WEBSITE. THESE MATERIALS
ARE NOT DIRECTED AT OR TO BE ACCESSED BY PERSONS RESIDENT IN ANY JURISDICTION
WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT
JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH ANY CONSENT OR
OTHER FORMALITY WHICH ADVANZ PHARMA CORP. LIMITED REGARDS AS UNDULY ONEROUS.
You are attempting to enter the area of this website that is designated for the
publication of documents and information in connection with ADVANZ PHARMA Corp.
Limited (“ADVANZ”) formal sale process.
The information contained in this area of this website is being made available
in good faith and for information purposes only in compliance with the City Code
on Takeovers and Mergers and is subject to the terms and conditions set out
below. In particular, the information contained in this area of this website
does not constitute an offer to sell or otherwise dispose of or any invitation
or solicitation of any offer to purchase or subscribe for any securities in any
jurisdiction in which such offer or solicitation is unlawful.
Access to the Website
If you would like to view this area of the website, please read this notice
carefully. This notice applies to all persons who view this area of the website
and, depending on where you are located, may affect your rights or
responsibilities. ADVANZ reserves the right to amend or update this notice at
any time and you should, therefore, read it in full each time you visit this
area of the website. In addition, the contents of this area of the website may
be amended at any time in whole or in part at the sole discretion of ADVANZ.
Overseas Persons
As a consequence of legal restrictions, the release, publication or distribution
of information contained in this area of the website in certain jurisdictions or
to certain persons may be restricted or unlawful. All persons resident or
located outside the United Kingdom who wish to view this area of the website
must first satisfy themselves that they are not subject to any local
requirements that prohibit or restrict them from doing so and should inform
themselves of, and observe, any applicable legal or regulatory requirements
applicable in their jurisdiction. If you are resident or located in a country
that renders the accessing of this area of the website or parts thereof illegal,
whether or not subject to making certain notifications or taking other action,
you should not view this area of the website.
It is your responsibility to satisfy yourself as to the full observance of any
relevant laws and regulatory requirements. If you are in any doubt, you should
not continue to seek to access this area of the website.
You should not forward, transmit or show the announcements, information or
documents contained in this area of the website to any person. In particular,
you should not forward or transmit the announcements, information or documents
contained in this area of the website to any jurisdiction where it would be
unlawful to do so.
Forward Looking Statements
This area of the website contains “forward-looking statements”. These statements
are based on the current expectations of the management of ADVANZ and are
naturally subject to uncertainty and changes in circumstances.
Forward-looking statements include, without limitation, statements typically
containing words such as “intend”, “expect”, “anticipate”, “target”, “estimate”,
“plan”, “strategy”, “will”, “should”, “may”, “goal”, “seek”, “believe”,
“predict”, “continue”, “future”, “could”, “can” and words of similar import.
These forward looking statements are not guarantees of future performance. By
their nature, forward-looking statements involve risk and uncertainty because
they relate to events and depend on circumstances that will occur in the future.
There are a number of factors that could cause actual results and developments
to differ materially from those expressed or implied by such forward-looking
statements. These factors include, but are not limited to, changes in economic
conditions, changes in the level of capital investment, success of business and
operating initiatives and restructuring objectives, costs associated with
research and development, changes in the prospects for products in the research
and development pipeline of ADVANZ, customers’ strategies and stability, changes
in the regulatory environment, fluctuations of interest and exchange rates, the
outcome of litigation, government actions and natural phenomena such as floods,
earthquakes and hurricanes. Other unknown or unpredictable factors could cause
actual results to differ materially from those in the forward-looking
statements. ADVANZ does not undertake any obligation to update publicly or
revise forward-looking statements, whether as a result of new information,
future events or otherwise, except to the extent legally required.
Given these risks and uncertainties, investors should not place undue reliance
on forward-looking statements as a prediction of actual results. Neither ADVANZ
nor any of its affiliated companies undertakes any obligation to update or
revise forward-looking statements, whether as a result of new information,
future events or otherwise, except to the extent legally required.
Responsibility
In relation to any document, announcement or information contained in this area
of the website, the only responsibility accepted by the directors of ADVANZ (the
“Responsible Persons”) is for the correctness and fairness of its reproduction
or presentation, unless the responsibility statement in any relevant document
expressly provides otherwise.
None of the Responsible Persons, ADVANZ or its affiliated companies have
reviewed and none of them is responsible for, or accepts any liability in
respect of, any information on any other website that may be linked to this
website by a third party.
The documents included in this area of the website speak only at the specified
date of the relevant document and neither ADVANZ nor any of its affiliated
companies has or accepts any responsibility or duty to update such documents
(other than to the extent such duty arises as a matter of law).
If you are in any doubt about the contents of this area of the website or the
action you should take, you should seek your own financial advice from an
independent financial adviser authorised under the Financial Services and
Markets Act 2000 or, if you are located outside the United Kingdom, from an
appropriately authorised independent financial adviser.
THE DOCUMENTS IN THIS AREA OF THE WEBSITE MAY NOT BE DOWNLOADED, FORWARDED,
TRANSMITTED OR SHARED WITH ANY OTHER PERSON EITHER IN WHOLE OR IN PART WHERE TO
DO SO WOULD OR MAY CONSTITUTE A BREACH OF ANY APPLICABLE LOCAL LAWS OR
REGULATIONS.
Electronic versions of these materials are not directed at or accessible by
persons resident in any jurisdiction where to do so would constitute a violation
of the relevant laws of such jurisdiction.
This notice shall be governed by, and interpreted in accordance with, English
law.
Confirmation of Understanding and Acceptance of Disclaimer. If you do not click
“I AGREE” below you will not be permitted access to this area of the website.
* I certify that I am not (nor do I act on behalf of someone who is) resident
in any country that renders the accessing of this area of the website or
parts thereof illegal.
* I agree that I will not forward, transfer or distribute (by any means
including by electronic transmission) any documents included in this area of
the website either in whole or in part to any person in any jurisdiction
where such distribution may be restricted by applicable law or regulation.
* I represent and warrant to ADVANZ that I intend to access this area of the
website for information purposes only, that I have read and understood this
notice and that I understand that it may affect my rights or
responsibilities.
* I agree to be bound by the terms of this notice.
I don't agree I agree